Latest liver cancer Stories
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
First-in-Class Agent is Well Tolerated in Liver Cancer Patients SAN ANTONIO, Jan.
Trial follows successful Phase I/II study which met all study endpoints PETACH TIKVA, Israel, Dec.
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
PETACH TIKVA, Israel, Nov. 18, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
Presented: Monday, November 10, 2014 - Hynes Convention Center, Boston, MA BOSTON, Nov.
LAWRENCEVILLE, N.J., Nov.
SAN ANTONIO, Texas, October 16, 2014 /PRNewswire/ -- GenSpera, Inc.
SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.
- totally perplexed and mixed up.